Suicide in Schizophrenia: An Educational Overview

被引:123
作者
Sher, Leo [1 ,2 ]
Kahn, Rene S. [1 ,2 ]
机构
[1] James J Peters Vet Adm Med Ctr, New York, NY 10468 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源
MEDICINA-LITHUANIA | 2019年 / 55卷 / 07期
关键词
suicide; schizophrenia; antipsychotics; depression; RISK-FACTORS; FOLLOW-UP; NATIONWIDE COHORT; 5-HYDROXYINDOLEACETIC ACID; ANTIPSYCHOTIC TREATMENTS; DEPRESSIVE SYMPTOMS; CEREBROSPINAL-FLUID; BEHAVIOR; MORTALITY; PREVENTION;
D O I
10.3390/medicina55070361
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Suicide is an important public health problem. The most frequent psychiatric illnesses associated with suicide or severe suicide attempt are mood and psychotic disorders. The purpose of this paper is to provide an educational overview of suicidal behavior in individuals with schizophrenia. A lifetime suicide rate in individuals with schizophrenia is approximately 10%. Suicide is the largest contributor to the decreased life expectancy in individuals with schizophrenia. Demographic and psychosocial factors that increase a risk of suicide in individuals with schizophrenia include younger age, being male, being unmarried, living alone, being unemployed, being intelligent, being well-educated, good premorbid adjustment or functioning, having high personal expectations and hopes, having an understanding that life's expectations and hopes are not likely to be met, having had recent (i.e., within past 3 months) life events, having poor work functioning, and having access to lethal means, such as firearms. Throughout the first decade of their disorder, patients with schizophrenia are at substantially elevated suicide risk, although they continue to be at elevated suicide risk during their lives with times of worsening or improvement. Having awareness of symptoms, especially, awareness of delusions, anhedonia, asociality, and blunted affect, having a negative feeling about, or non-adherence with, treatment are associated with greater suicide risk in patients with schizophrenia. Comorbid depression and a history of suicidal behavior are important contributors to suicide risk in patients with schizophrenia. The only reliable protective factor for suicide in patients with schizophrenia is provision of and compliance with comprehensive treatment. Prevention of suicidal behavior in schizophrenia should include recognizing patients at risk, delivering the best possible therapy for psychotic symptoms, and managing comorbid depression and substance misuse.
引用
收藏
页数:11
相关论文
共 102 条
  • [1] Adams CE, 2000, COCHRANE DB SYST REV, V2
  • [2] Aguilar EJ, 2007, PSYCHOPHARMACOL BULL, V40, P128
  • [3] Major Physical Health Conditions and Risk of Suicide
    Ahmedani, Brian K.
    Peterson, Edward L.
    Hu, Yong
    Rossom, Rebecca C.
    Lynch, Frances
    Lu, Christine Y.
    Waitzfelder, Beth E.
    Owen-Smith, Ashli A.
    Hubley, Samuel
    Prabhakar, Deepak
    Williams, L. Keoki
    Zeld, Nicole
    Mutter, Elizabeth
    Beck, Arne
    Tolsma, Dennis
    Simon, Gregory E.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2017, 53 (03) : 308 - 315
  • [4] Amaresha Anekal C, 2012, Indian J Psychol Med, V34, P12, DOI 10.4103/0253-7176.96149
  • [5] [Anonymous], 1919, Suddeutsche Monatshafte, V16, P171
  • [6] Balhara Y Ps, 2012, East Asian Arch Psychiatry, V22, P126
  • [7] Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period
    Barak, Y
    Mirecki, I
    Knobler, HY
    Natan, Z
    Aizenberg, D
    [J]. PSYCHOPHARMACOLOGY, 2004, 175 (02) : 215 - 219
  • [8] Suicidality before and in the early phases of first episode psychosis
    Barrett, Elizabeth A.
    Sundet, Kjetil
    Faerden, Ann
    Nesvag, Ragnar
    Agartz, Ingrid
    Fosse, Roar
    Mork, Erlend
    Steen, Nils Eiel
    Andreassen, Ole A.
    Melles, Ingrid
    [J]. SCHIZOPHRENIA RESEARCH, 2010, 119 (1-3) : 11 - 17
  • [9] Cognitive behavioral therapy reduces suicidal ideation in schizophrenia: Results from a randomized controlled trial
    Bateman, Katy
    Hansen, Lars
    Turkington, Douglas
    Kingdon, David
    [J]. SUICIDE AND LIFE-THREATENING BEHAVIOR, 2007, 37 (03) : 284 - 290
  • [10] Structured diagnostic assessment and depot fluphenazine treatment of multiple suicide attempters in the emergency department
    Battaglia, J
    Wolff, TK
    Wagner-Johnson, DS
    Rush, AJ
    Carmody, TJ
    Basco, MR
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (06) : 361 - 372